All Type of News
Pharmaceutical company increased cash account and reduced debt ratio.
According to "Financial analysis and investment advice of pharmaceutical industry" reported by Mr. Ha Tae-ki, the assistant manage in charge of pharmaceutical business, SK security company after analysing the financia...
M&A and Big Deals in pharmaceutical industry rootlessly rumoured
Rootless rumours widely spreaded that big deals between the top drug makers and M&A by domestic conglomerates were attempted, which was voiced loudly in the stock exchange market where "the confidential letter for int...
5 listed drug makers announced to give dividends.
The Korea Stock Exchange announced publicly that 5 drugs makers including Bukwang (fiscal year closed at Dec. 31, 1998) planned to pay dividends to their stockholders.
Bukwang will pay 0.1 stock per a stock or in c...
Advertising and marketing promotion activity extremely slow due to IMF economic difficulties.
According to the financial analysis against KSE listed drug companies (account closing at Dec. 31), he advertising and market promotional expenditures in 1998 recorded extremely low by 33% and 20% decreases over the p...
KMA and KPA agreed to derive accorded medical/pharmacy separation bill in 2 months.
For celebration of the 45th anniversary of the Yakup Shinmoon Dr. Yu Sung-hee, the President of Korea Medical Association (KMA) and Mr. Kim Hee-joong, the President of Korea Pharmaceutical Association (KPA) were invit...
New working standards for insurance drug price now under review.
Upon request by readers a full text of the revised draft for "the detailed working standards for determination of medical insurance drug price and review on new registration" is herein transmitted.
The detailed...
KSE Listed drug companies remarkably improved debt ratio
The financial structures of listed drug companies having their accounts closed at Dec. 31, 1998 showed 177.05% of debt ratio, which was substantially improved even under the IMF economic crisis and difficu...
Domestic companies called to a bout on insecticide market with foreign invested firms.
3 domestic drug companies, Kukje, Kwangdong and Samhyup Boopum, are launching their new products to the insecticide markets, and 3 foreign invested companies, Bayer, Johnson and Crorax seemed to take a market leaders...
Dr. Yang Kyu-whan informally appointed as head of Toxicology Research Institute.
Dr. Yang Kyu-whan, the professor of Biology, Korea Institute of Science and Technology, was informally decided to appoint as the head of Korea Research Institute of Toxicology affiliated to the KFDA in the first speci...
Strategic business tie-up surged between local and foreign invested firms.
A strategic cooperation between domestic and foreign invested drug companies has surged to a remarkable progress these days for an exchange of their business strengths, being reciprocated with strong and nationwid...
